Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
8.94
+0.58 (6.87%)
At close: Nov 20, 2024, 4:00 PM
8.99
+0.05 (0.56%)
Pre-market: Nov 21, 2024, 6:37 AM EST

Sensus Healthcare Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Sensus Healthcare stock have an average target of 12.5, with a low estimate of 11 and a high estimate of 14. The average target predicts an increase of 39.82% from the current stock price of 8.94.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $11 $12.5 $14 $14
Change +23.04% +39.82% +56.60% +56.60%

Analyst Ratings

The average analyst rating for SRTS stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 222222
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$10$11
Strong Buy Maintains $10$11 +23.04% Nov 18, 2024
Maxim Group
Maxim Group
Strong Buy
Maintains
$12$14
Strong Buy Maintains $12$14 +56.60% Nov 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong Buy Reiterates $10 +11.86% Aug 12, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$8$10
Strong Buy Maintains $8$10 +11.86% May 13, 2024
Maxim Group
Maxim Group
Strong Buy
Maintains
$7$10
Strong Buy Maintains $7$10 +11.86% May 10, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
37.86M
from 24.41M
Increased by 55.14%
Revenue Next Year
46.10M
from 37.86M
Increased by 21.75%
EPS This Year
0.40
from 0.03
Increased by 1,242.15%
EPS Next Year
0.59
from 0.40
Increased by 47.13%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
27.26M9.58M27.04M44.53M24.41M37.86M46.10M58.06M
Revenue Growth
3.16%-64.87%182.36%64.68%-45.20%55.14%21.75%25.95%
EPS
-0.10-0.420.251.460.030.400.590.72
EPS Growth
---484.00%-97.96%1,242.15%47.13%22.94%
Forward PE
-----22.3315.1812.34
No. Analysts -----664
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 39.4M 51.5M 60.3M
Avg 37.9M 46.1M 58.1M
Low 35.7M 41.1M 55.3M

Revenue Growth

Revenue Growth 202420252026
High
61.6%
36.1%
30.7%
Avg
55.1%
21.8%
25.9%
Low
46.1%
8.6%
20.0%

EPS Forecast

EPS 202420252026
High 0.48 0.65 0.83
Avg 0.40 0.59 0.72
Low 0.35 0.49 0.62

EPS Growth

EPS Growth 202420252026
High
1,519.2%
62.6%
40.8%
Avg
1,242.2%
47.1%
22.9%
Low
1,082.7%
22.4%
4.8%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.